生命科学资讯

Astellas tops expectations as Vyloy sales surge outshines trial setback

Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA

Flagship-founded antibody biotech Generate is latest to mull IPO

A cut above: Veradermics locks in $256M IPO and shares spike

Angitia raises $130M to challenge Amgen with bone-building bispecifics

GE HealthCare posts higher full-year revenues amid turbulent tariff backdrop

Eikon's upsized $381M Nasdaq listing marks largest biotech IPO since 2024

Quell halts liver transplant Treg trial to focus on preclinical 'chill not kill' candidate

FDA’s rare pediatric disease voucher program revived by 2026 government funding bill

Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates

Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout

GSK's new CEO looking for $2B to $4B deals 'hiding in plain sight'

Medtronic steps up with up to $585M deal for Israeli devicemaker CathWorks

FDA demands better response from Abbott over Libre inspection violations

Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq

Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform

NHS 'FIT' bowel cancer test reduced unnecessary referrals as cancer numbers remain stable

Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1

Amgen advances toward lupus redemption while gastric cancer candidate struggles

HHS launches $100M antiviral prize to develop broad-spectrum therapies